Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12109196
Non-sedating dexmedetomidine treatment regimens
granted -
US 12109230
Treatment of neurodegenerative disease with sodium chlorite
granted -
US 12109225
Methods for potentiating cancer treatment using ionizing radiation
granted -
US 12109231
Treatment of neurodegenerative disease with sodium chlorite
granted -
US 12109229
Treatment of neurodegenerative disease with sodium chlorite
granted -
US 12109272
Intermittent dosing of glucocorticoid receptor modulators for the treatment of ovarian and other cancers
granted -
US 12109228
Treatment of neurodegenerative disease with sodium chlorite
granted -
US 12109201
Methods and compositions for treatment of epileptic disorders
granted -
PT 3721882
TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
granted -
US 12104163
Adeno-associated virus vectors for treatment of Rett syndrome
granted -
US 12102646
Compositions for the treatment of fibrosis and inflammation
granted -
US 12102642
Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators
granted -
US 12102640
Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration
granted -
US 12097198
Treatment of prostate cancer
granted -
US 12098118
Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
granted -
US 12097213
Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapy
granted -
US 12097188
Compositions and methods for the treatment of macular degeneration
granted -
US 12091397
Dihydroquinolinones for medical treatment
granted -
US 12090140
Non-sedating dexmedetomidine treatment regimens
granted -
US 12090142
Combination therapy for the treatment of cancer
granted -
US 12084473
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 12083184
Hydrogel prodrug for treatment
granted -
US 12083192
Methods for treatment of patients with myelodysplastic syndromes
granted -
US 12083141
Treatment of hyperglycemia with solute carrier family 39 member 5 (SLC39A5) inhibitors
granted